Evidence map›Paper›PMID 27502627›Full record

ArticleCancer epidemiology2016

Cancer burden in four countries of the Middle East Cancer Consortium (Cyprus; Jordan; Israel; Izmir (Turkey)) with comparison to the United States surveillance; epidemiology and end results program.

Hoda Anton-Culver, Jenny Chang, Freddie Bray, Ariana Znaor, Lisa Stevens, Sultan Eser, Barbara Silverman, Omar Nimri, Pavlos Pavlou, Haris Charalambous and 3 more

Open access · bronzeAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer epidemiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Breast Cancer Knowledge, Attitudes and Practices amongst Women in Qatar.International journal of environmental research and public health · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Role of natural killer cells in lung cancer.Journal of cancer research and clinical oncology · 2018
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Hoda Anton-CulverDepartment of Epidemiology, University of California Irvine, USA. Electronic address: hantoncu@uci.edu.
Jenny ChangDepartment of Epidemiology, University of California Irvine, USA.
Freddie BrayInternational Agency of Research on Cancer, France.
Ariana ZnaorInternational Agency of Research on Cancer, France.
Lisa StevensCenter for Global Health, National Cancer Institute, USA.
Sultan EserIzmir Cancer Registry, Izmir & Hacettepe University, Ankara, Turkey.
Barbara SilvermanIsrael National Cancer Registry, Israel.
Omar NimriNational Cancer Registry of Jordan, Jordan.
Pavlos PavlouCyprus Cancer Registry, Cyprus.
Haris CharalambousCyprus Cancer Registry, Cyprus.
Anna DemetriouCyprus Cancer Registry, Cyprus.
Kevin WardGeorgia Cancer Registry, Emory University, USA.
Argyrios ZiogasDepartment of Epidemiology, University of California Irvine, USA.
University of California, Irvine · USCentre international de recherche sur le cancer · FRCenter for Global Health · USEmory University · USHacettepe University · TR

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
NCI NIH HHS P30 CA062203
6 · The paper itself

Abstract

It is important that population-based cancer registries provide accurate and reliable data for public health purposes. These data are essential data for planning of cancer control and prevention. In this study, we examined cancer incidence rates (year 2005-2010) in four MECC registries (Cyprus, Jordan, Israel, Izmir (Turkey)) and compared with the rates in the US. The overall age-standardized incidence rates for males were highest in the US followed by Israeli Jews, Izmir (Turkey), Cyprus, Israeli Arabs, and lowest in Jordan. In women the rates of cancer of all sites were also highest in US women followed by Israeli Jews, Cyprus, Israeli Arabs, Izmir (Turkey), and lowest in Jordan. It is of interest that although site-specific cancer rates differ between the countries studied, prostate, lung and colorectal cancers are within the five most common cancers males in all countries studied. In females, breast colorectal and endometrium cancers are three of the five most common cancers in females in all countries studied. The results presented in this paper can have implications for opportunities in cancer control and prevention in these countries. Future studies on individual cancer sites with highest rates in these Countries are currently underway.

Indexed as

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolCyprusFemaleHumansIncidenceInfantInfant, NewbornIsraelJordanMaleMiddle AgedCancer burdenCancer riskMiddle EastPopulation-based cancer registriesSEER

Identifiers

PMID27502627
PMCPMC7853241
OpenAlexW2490012087

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.